Molekule

Advanced air purification solutions provider

San Francisco, California, United States

About Molekule

Molekule specializes in air purification solutions aimed at improving indoor air quality for homes, schools, and businesses. Its main products are air purifiers that utilize PECO (Photo Electrochemical Oxidation) technology and HEPA (High-Efficiency Particulate Air) filters. These filters not only capture but also destroy harmful pollutants like viruses, pet dander, mold, and smoke. Molekule sells its air purifiers directly through its website and through retail partnerships, and it also offers subscription services for replacement filters, creating a steady revenue stream. The company stands out from competitors due to its strong scientific foundation, with PECO technology validated by research from reputable universities. Molekule's goal is to ensure clean air in every room and home, enhancing the health and wellness of its customers.

San Francisco, CaliforniaHeadquarters
2014Year Founded
$103.5MTotal Funding
IPOCompany Stage
Healthcare, Consumer GoodsIndustries
51-200Employees

Risks

Competition from brands like Dyson and Blueair may impact Molekule's market share.
COO resignation could disrupt operational leadership and strategic direction.
Dependency on third-party retailers like Crate & Barrel may affect profit margins.

Differentiation

Molekule's PECO technology destroys pollutants at a molecular level, unlike HEPA filters.
The company's air purifiers are FDA-cleared, ensuring high safety and efficacy standards.
Molekule's sleek design and scientific validation set it apart in the air purifier market.

Upsides

Increased demand for air purifiers due to COVID-19 boosts Molekule's market potential.
Smart home integration trend offers Molekule opportunities for enhanced product appeal.
Growing wildfire smoke concerns position Molekule's products as essential in affected regions.

Funding

Total raised$103.50 M
Latest valuation$290.00 M
StageIPO
PRIVATE PLACEMENT VC
4/30/2023
$10
POST IPO EQUITY
6/30/2022
$40
SEED
4/30/2016
$3
$16.50 M